Skip to content

Arthrex® AR-9564-2442-LATRecalls & reported problems

Arthrex, Inc. · 42 +4 LAT/24 Glenosphere · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00888867295742), received between Dec 20, 2019 and Nov 8, 2024 — classified as 3 injuries.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Dislodged or Dislocated1
  • Fitting Problem1

Patient problems

  • Anemia1
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Atrial Fibrillation1
  • Hematoma1
  • Insufficient Information1
  • Pain1
  • Tissue Breakdown1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 8, 2024Device Dislodged or Dislocated; Device Dislodged or Dislocated

    ON 10/28/2024, IT WAS REPORTED BY A SALES REPRESENTATIVE VIA EMAIL THAT AN AR-9564-2442-LAT GLENOSPHERE AND GLENOSPHERE SET SCREW DISENGAGED FROM THE BASEPLATE. THE PATIENT UNDERWENT SURGERY ON (B)(6) 2023 FOR A REVERSE SHOULDER ARTHROPLASTY. POSTOPERATIVELY THE PATIENT EXPERIENCED PAIN AND A CT SCAN REVEALED GLENOSPHERE AND GLENOSPHERE SET SCREW DISENGAGED FROM THE BASEPLATE. ON 10/16/23 THE PATIENT UNDERWENT A REVISION SURGERY IN WHICH A NEW GLENOSPHERE ALONG WITH HUMERAL COMPONENTS WERE IMPLANTED. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: Pain

    MAUDE report 20640183 ↗
  • InjuryApr 21, 2023Fitting Problem; Fitting Problem

    ON (B)(6) 2023, IT WAS REPORTED BY A SALES REPRESENTATIVE VIA EMAIL THAT AN AR-9564-2442-LAT ARTHREXUNIVERS REVERS MODULAR GLENOID SYSTEM GLENOSPHERE WOULD SPIN AROUND THE BASEPLATE WHEN THE SCREW WAS ATTEMPTING TO BE TORQUED. THIS WAS DISCOVERED DURING A REVISION REVERSE TOTAL SHOULDER PROCEDURE ON (B)(6) 2023. A NEW GLENOSPHERE WAS USED TO COMPLETE THE CASE.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Insufficient Information

    MAUDE report 16785318 ↗
  • InjuryDec 20, 2019Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED VIA THE SURGICAL OUTCOME SYSTEM THAT A PATIENT WAS HAVING COMPLICATIONS POSSIBLY RELATED TO A PRIOR IMPLANTED ARTHREX PRODUCT. COMPLICATIONS MENTIONED WERE HEMATOMA. ADDITIONAL INFORMATION OBTAINED 12/3/2019: THE SURGEON'S REPRESENTATIVE HAS CONFIRMED THAT A PATIENT HAD AN INITIAL PRIOR ROTATOR CUFF REPAIR AND REQUIRED A SECOND LEFT REVERSE SHOULDER ARTHROPLASTY ON (B)(6) 2019. THE OPERATIVE REPORT FROM (B)(6) 2019 NOTED THAT THREE METAL CORKSCREW ANCHORS HAD BEEN EXPLANTED PRIOR TO PROCEEDING WITH THE PROCEDURE. DURING THE PROCEDURE THE FOLLOWING ARTHREX PRODUCTS WERE IMPLANTED: AR-9564-2442-LAT (MODULAR GLENOSPHERE), AR-9501-07S (HUMERAL STEM) AND AR-9502F-42LCPC (SUTURE CUP). ON (B)(6) 2019 THE PATIENT WAS ADMITTED TO THE HOSPITAL URGENTLY AFTER HIS LARGE HEMATOMA BEGAN TO HAVE WOUND BREAKDOWN AND HE HAD ANEMIA WITH SYMPTOMATIC ATRIAL FIBRILLATION WITH RVR. SURGEON ADMITTED THE PATIENT FOR SURGICAL EXPLORATION WITH EVACUATION OF HEMATOMA, DEBRIDEMENT, EXPLORATION OF TENDON TRANSFER SITE AND ADMINISTRATION OF LOCAL ANTIBIOTICS. OPERATIVE REPORT NOTED THERE WAS NO EVIDENCE OF INFECTION AND THE SUBSCAPULARIS REPAIR AND THE TENDON TRANSFER REPAIR WERE INTACT. THE PRO

    Patient problems: Anemia; Atrial Fibrillation; Hematoma; Tissue Breakdown

    MAUDE report 9506054 ↗

Other shoulder prosthesis, reverse configuration devices

All shoulder prosthesis, reverse configuration devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page